LABU TNA TQQQ Calls

Sold LABU Dec 02 2022 7.0 Diagonal Calls at $0.21
Sold LABU Dec 02 2022 7.5 Diagonal Calls at $0.07 and $0.11
(Biogen shares are trading higher after the company announced trial results for its experimental Alzheimer’s drug lecanemab.)

Sold 1 TNA Dec 02 2022 40.0 Covered Call at $0.19
Sold 1 TNA Dec 02 2022 40.5 Covered Call at $0.12

Sold TQQQ Dec 02 2022 22.5 Covered Calls at $0.21 up to $0.24
Sold TQQQ Dec 02 2022 23.0 Covered Call at $0.20
Sold TQQQ Dec 02 2022 23.5 Covered Calls at $0.07